drugset / Trial / NCT01789320
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to determine the safety and tolerability of a single microinjection of triamcinolone acetonide (TRIESENCE®) into the suprachoroidal space (SCS) of patients who have non-infectious uveitis.
Timeline
- Start
- 2013-02
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triamcinolone Acetonide | Other / unclassified | 4 mg | Other |